Literature DB >> 30508384

Carboxypeptidase E-ΔN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-β-catenin pathway.

Shuli Fan1, Xiang Gao2, Peng Chen2, Xu Li2.   

Abstract

Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents, and metastatic OS is the major cause of OS-related death. Carboxypeptidase E (CPE) is known to be highly expressed in some cancer types, and its N-terminal truncated form, CPE-ΔN, is implicated in tumor metastasis and poor prognosis. In this study, we investigated the effect of CPE-ΔN on cell migration, invasiveness, and the epithelial-mesenchymal transition (EMT) of OS cells, and illustrated the molecular mechanisms. We first constructed CPE-ΔN overexpressing human OS cell lines (143B and U2OS cells), and found that ectopic CPE-ΔN expression in OS cells enhanced cell migration and invasiveness, and promoted the EMT process. Further, overexpression of CPE-ΔN increased the levels of c-myc and nuclear β-catenin in OS cells, which suggested the CPE-ΔN promotes activation of the Wnt-β-catenin pathway in OS cells. Treatment with β-catenin small interfering RNA (siRNA) inhibited the migration and invasiveness of CPE-ΔN-overexpressing cells, and reduced the expression of E-cadherin. Together, these results suggest that CPE-ΔN promotes migration, invasiveness, and the EMT of OS cells via the Wnt-β-catenin signaling pathway.

Entities:  

Keywords:  carboxypeptidase E; epithelial–mesenchymal transition; metastasis; métastase; osteosarcoma; ostéosarcome; transition épithélio-mésenchymateuse; β-catenin; β-caténine

Mesh:

Substances:

Year:  2018        PMID: 30508384     DOI: 10.1139/bcb-2018-0236

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  6 in total

Review 1.  Carboxypeptidase E and its splice variants: Key regulators of growth and metastasis in multiple cancer types.

Authors:  Sangeetha Hareendran; Xuyu Yang; Vinay Kumar Sharma; Y Peng Loh
Journal:  Cancer Lett       Date:  2022-08-18       Impact factor: 9.756

2.  Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma.

Authors:  Ting Xu; Zhe Zhang; Hongqiang Chen; Ruili Cai; Qian Yang; Qi Liu; Yahan Fan; Wenbin Liu; Chunyan Yao
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

3.  Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression.

Authors:  Sangeetha Hareendran; Xuyu Yang; Hong Lou; Lan Xiao; Y Peng Loh
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

4.  Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway.

Authors:  Yangyang Fu; Lihuang Su; Mengsi Cai; Boyang Yao; Sisi Xiao; Qinlian He; Le Xu; Lehe Yang; Chengguang Zhao; Tingting Wan; Lianyou Shao; Liangxing Wang; Xiaoying Huang
Journal:  Mol Carcinog       Date:  2019-08-09       Impact factor: 4.784

5.  Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis.

Authors:  Junfeng Guo; Hong Tang; Pan Huang; Junfeng Guo; Youxing Shi; Chengsong Yuan; Taotao Liang; Kanglai Tang
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738

6.  Exosomal Carboxypeptidase E (CPE) and CPE-shRNA-Loaded Exosomes Regulate Metastatic Phenotype of Tumor Cells.

Authors:  Sangeetha Hareendran; Bassam Albraidy; Xuyu Yang; Aiyi Liu; Anne Breggia; Clark C Chen; Y Peng Loh
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.